Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CorMedix (CRMD) Tax Provisions (2024 - 2025)

Historic Tax Provisions for CorMedix (CRMD) over the last 7 years, with Q3 2025 value amounting to -$56.0 million.

  • CorMedix's Tax Provisions fell 107059334.61% to -$56.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$55.5 million, marking a year-over-year decrease of 387628.75%. This contributed to the annual value of -$1.4 million for FY2024, which is 19298.47% down from last year.
  • CorMedix's Tax Provisions amounted to -$56.0 million in Q3 2025, which was down 107059334.61% from $521507.0 recorded in Q2 2025.
  • CorMedix's Tax Provisions' 5-year high stood at $521507.0 during Q2 2025, with a 5-year trough of -$56.0 million in Q3 2025.
  • Its 4-year average for Tax Provisions is -$8.4 million, with a median of -$585617.0 in 2022.
  • Over the last 5 years, CorMedix's Tax Provisions had its largest YoY gain of 1007145.32% in 2025, and its largest YoY loss of 107059334.61% in 2025.
  • Quarter analysis of 4 years shows CorMedix's Tax Provisions stood at -$1.3 million in 2021, then surged by 53.16% to -$585617.0 in 2022, then skyrocketed by 100.89% to $5230.0 in 2024, then tumbled by 1070593.35% to -$56.0 million in 2025.
  • Its Tax Provisions was -$56.0 million in Q3 2025, compared to $521507.0 in Q2 2025 and $5230.0 in Q3 2024.